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Accepted 13 June 2013AbstractObjective: To present prenatal diagnosis of mosaic trisomy 2.
Materials and Methods: A 29-year-old woman underwent amniocentesis at 17 weeks of gestation because of abnormal maternal serum
screening, and the cytogenetic result was 47,XY,þ2[8]/46,XY[22]. She underwent repeated amniocentesis at 19 weeks of gestation. Interphase
fluorescence in situ hybridization (FISH), array comparative genomic hybridization (aCGH), and quantitative fluorescent polymerase chain
reaction (QF-PCR) were performed on uncultured amniocytes. Ultrasound at 22 weeks of gestation revealed severe oligohydramnios, intra-
uterine growth restriction, and ventricular septal defect. The pregnancy was terminated at 22 weeks of gestation. Cytogenetic analysis was
performed on parental blood, cultured amniocytes, cord blood, skin, liver, lung, umbilical cord, amnion, and placenta. aCGH analysis was
performed on cord blood, skin, and liver.
Results: In the samples of uncultured amniocytes, interphase FISH detected 11.1% (13/117) mosaicism for trisomy 2, aCGH analysis showed the
result of arr [hg19] 2p25.3q37.3 (0e242,936,883)2.46, and QF-PCR excluded uniparental disomy 2. QF-PCR on placenta revealed trisomy 2
derived from maternal meiosis I non-disjunction. Cytogenetic analysis revealed the following results: cultured amniocytes: 46,XY[21 colonies];
cord blood: 46,XY[40 cells]; skin: 46,XY[40 cells]; lung: 46,XY[40 cells]; liver: 47,XY,þ2[4 cells]/46,XY[36 cells]; umbilical cord: 47,XY,þ2
[4 cells]/46,XY[36 cells]; amniotic membrane: 47,XY,þ2[20 cells]/46,XY[20 cells]; and placenta: 47,XY,þ2[40 cells]. The fetus postnatally
manifested facial dysmorphism and preaxial polydactyly of the hand.
Conclusion: Interphase FISH and aCGH analyses on uncultured amniocytes are useful for rapid confirmation of low-level mosaic trisomy 2 at
amniocentesis.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Prenatal diagnosis of mosaic trisomy 2 at amniocentesis is
uncommon. To date, only 19 cases of prenatally detected
mosaic trisomy 2 at amniocentesis have been reported [1e3].
The prevalence of mosaic trisomy 2 in chorionic villus sam-
pling is about one in 2000 samples [4e7]. The prevalence of
mosaic trisomy 2 at amniocentesis is about one in 58,000
amniocenteses [8]. Mosaic trisomy 2 may prenatally be
associated with elevated maternal serum a-fetoprotein,
abnormal maternal serum screening, and abnormal ultrasound
findings such as intrauterine growth restriction (IUGR), oli-
gohydramnios, congenital heart defects, ventriculomegaly,
spina bifida, and hydronephrosis [2]. Here, we present our
experience of a prenatal diagnosis of mosaic trisomy 2 by
amniocentesis in a fetus associated with abnormal maternal
serum screening, oligohydramnios, IUGR, ventricular septal
defect, preaxial polydactyly, and facial dysmorphism.Materials and methodsClinical descriptionA 29-year-old, gravid 2, para 1, woman was referred to the
hospital at 19 weeks of gestation for genetic counseling
because of mosaic trisomy 2 at amniocentesis. Her husband
was 30 years old. She and her husband were non-
consanguineous and healthy, and there was no family history
of congenital malformations. During this pregnancy, the
maternal serum screening at 12þ4 weeks of gestation revealed
a Down syndrome risk of 1:12 calculated from maternal age,
nuchal translucency of 2.2 mm, a high maternal serum free
b-human chorionic gonadotrophin (MSfreeb-hCG) level of
2.828 multiples of the median (MoM) and a low maternalFig. 1. Interphase fluorescence in situ hybridization analysis on uncultured amnio
spectrum green, fluorescein isothiocyanate) shows (A) three green signals in a cell
consistent with the diagnosis of mosaic trisomy 2.serum pregnancy-associated plasma protein-A (MSPAPP-A)
level 0.246 MoM. She underwent amniocentesis at 17 weeks
of gestation, and the result revealed a karyotype of 47,XY,þ2
[8]/46,XY[22]. Among 30 cultured amniocytes by in situ
culture, eight colonies had the karyotype of 47,XY,þ2,
whereas the remaining 22 colonies had the karyotype of
46,XY. Prenatal ultrasound at 19 weeks of gestation revealed a
singleton fetus with fetal biometry equivalent to 17 weeks and
oligohydramnios. The woman requested repeated amniocen-
tesis, which was performed at 19 weeks of gestation. Inter-
phase fluorescence in situ hybridization (FISH), array
comparative genomic hybridization (aCGH), and quantitative
fluorescent polymerase chain reaction (QF-PCR) were per-
formed on uncultured amniocytes. Conventional cytogenetic
analysis was performed on cultured amniocytes and parental
blood. Level II ultrasound at 22 weeks of gestation revealed
severe oligohydramnios, IUGR, and ventricular septal defect.
The parents decided to terminate the pregnancy at 22 weeks of
gestation. Cytogenetic analysis was performed on the cultured
tissues of cord blood, skin, liver, lung, umbilical cord, amni-
otic membrane, and placenta. aCGH analysis was performed
on uncultured cord blood, skin, and liver.aCGHWhole-genome aCGHon theDNAextracted fromuncultured
amniocytes derived from 10mL of amniotic fluid was performed
using NimbleGen ISCA Plus Cytogenetic Array (Roche Nim-
bleGen, Madison, WI, USA). The NimbleGen ISCA Plus Cy-
togenetic Array has 630,000 probes and a median resolution of
15e20 kb across the entire genome. The DNA from the cells in
amniotic fluid was extracted first. It was done by following the
manufacturer’s protocol of the QIAamp DNAMini kit (Qiagen,
Valencia, CA, USA). Then, 0.5mg of extracted DNAwas labeledcytes using the bacterial artificial chromosome probe RP11-468G5 (2q11.1;
with trisomy 2 and (B) two green signals in a cell with disomy 2. The result is
Fig. 2. Array comparative genomic hybridization on the DNA extracted from uncultured amniocytes shows a 242.9-Mb partial duplication of 2p25.3-q37.1, or arr
[hg19] 2p25.3q37.1 (0-242,936,883)2.46]. The duplicated segment has a log2 ratio of 0.3, indicating mosaicism in the uncultured amniocytes. (A) Whole-
genome view, (B) chromosomal view, and (C) zoom in view.
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female genomic DNA (G1521; Promega) labeled in Cy3 dye to
perform aCGH. The experiment was performed according to the
procedures recommended from the users’ guide for the Roche
NimbleGen ISCA plus Cytogenetic Array. The data were finally
represented by using Nexus 6.1 (BioDiscovery, Hawthorne, CA,
USA). Whole-genome aCGH on the DNA extracted from un-
cultured cord blood, skin, and liver was also performed using the
same kit and the same method.QF-PCRQF-PCR analysis was performed on the DNA extracted from
uncultured amniocytes, placental tissues, and parental blood as
described previously [9]. Briefly, primers specifically flanking
short tandem repeat markers on chromosome 2q region such as
D2S1771 (2q14.1), D2S1399 (2q22.3), D2S1384 (2q33.3), andD2S1279 (2q37.1) were applied to undertake polymorphic
marker analysis to exclude uniparental disomy (UPD) and to
determine the parental origin of genomic imbalance if detected.FISHInterphase FISH analysis was performed on 117 uncultured
amniocytes using 2q11.1-specific bacterial artificial chromo-
some probe RP11-468G5 encompassing 95,903,645e96,
106,005 (NCBI build 37; spectrum green, fluorescein iso-
thiocyanate) according to the standard FISH protocol
described elsewhere [10].Conventional cytogenetic analysisRoutine cytogenetic analysis by G-banding techniques at
the 550 bands of resolution was performed. About 16 mL of
Fig. 3. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction assays on the DNA extracted from uncultured amnio-
cytes and placental tissue. In the uncultured amniocytes, the markers D2S1399
(2q22.3) and D2S1279 (2q37.1) show two peaks (163 bp: 175 bp; paternal:
maternal) and (154 bp: 162 bp; paternal: maternal), respectively of equal
fluorescent activity from two different parental alleles. The result excludes
uniparental disomy 2. In the placental tissue, the markers D2S1399 (2q22.3)
and D2S1279 (2q37.1) show three peaks (147 bp: 163 bp: 175 bp; maternal:
paternal: maternal) and (154 bp: 158 bp: 162 bp; paternal: maternal: maternal),
respectively of equal fluorescent activity from one paternal allele and two
different maternal alleles with a 1:1:1 ratio. The result is consistent with tri-
somy 2 of maternal origin and maternal meiosis I non-disjunction.
Fig. 4. A karyotype
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in situ amniocyte culture. Twenty-one colonies of cultured
amniocytes were investigated in the in situ culture of amnio-
cytes. Parental blood was collected, and the samples were
subjected to lymphocyte culture. Forty cultured cells were
investigated in the cultures of fetal and extraembryonic tissues.
Results
Interphase FISH analysis on uncultured amniocytes showed
three green signals of the 2q11.1-specific probe of RP11-
468G5 in 11.1% (13/117) of the cells and two green signals
in the remaining 88.9% (114/117) of the cells, indicating a
11.1% mosaicism for trisomy 2 in the uncultured amniocytes
(Fig. 1). Whole-genome aCGH analysis on the DNA extracted
from uncultured amniocytes detected a 242.9-Mb duplication
of 2p25.3-q37.3, or arr [hg19] 2p25.3q37.3 (0-242,936,883)
2.46 (Fig. 2). The duplicated segment had a log2 ratio of 0.3,
indicating mosaicism in the uncultured amniocytes. Whole-
genome aCGH analysis on the DNA extracted from cord
blood, skin, and liver revealed no genomic imbalance in
chromosome 2. QF-PCR analysis on the DNA extracted from
uncultured amniocytes and parental blood revealed a bipa-
rental diallelic pattern for chromosome-2-specific markers and
thus excluded UPD 2 in the fetus (Fig. 3). QF-PCR analysis on
the DNA extracted from uncultured placental tissues revealed
a triallelic pattern with a dosage ratio of 1:1:1 (paternal:
maternal: maternal) for chromosome-2-specific markers,
indicating a maternal origin of trisomy 2 and the occurrence of
non-disjunction in maternal meiosis I in the placenta (Fig. 3).of 47,XY,þ2.
Fig. 5. Craniofacial appearance of the fetus at birth.
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netic analysis of cultured amniocytes, fetal tissues, and
extraembryonic tissues revealed the following karyotypes:
cultured amniocytes: 46,XY[21 colonies]; cord blood: 46,XY
[40 cells]; skin: 46,XY[40 cells]; lung: 46,XY[40 cells]; liver:
47,XY,þ2[4 cells]/46,XY[36 cells]; umbilical cord: 47,XY,þ2
[4 cells]/46,XY[36 cells]; amniotic membrane: 47,XY,þ2[20
cells]/46,XY[20 cells]; and placenta: 47,XY,þ2[40 cells]
(Fig. 4). A 420-g malformed male fetus was delivered with
micrognathia, depressed nasal bridge, low-set ears, and pre-
axial polydactyly of the right hand (Figs. 5 and 6).
Discussion
The present case provides evidence for the association of
mosaic trisomy 2 with abnormal maternal serum screening in
the first trimester. The present case was associated with a 1:12
risk of Down syndrome calculated from a high level of
MSfreeb-hCG and a low level of MSPAPP-A at 12 weeks of
gestation. Mosaic trisomy 2 has been associated with elevated
maternal serum a-fetoprotein and abnormal maternal serum
screening in the second trimester [8,11e16]. The present case
manifested a high level of MSfreeb-hCG. Harrison et al [12]
reported an elevated MShCG level of 3.67 MoM in aFig. 6. Preaxial polydactyly of the right hand.pregnancy with mosaic trisomy 2 and maternal UPD 2. Rob-
erts et al [16] reported an elevated MShCG level of 3.9 MoM
in a pregnancy with mosaic trisomy 2, IUGR, and oligohy-
dramnios. The present case additionally shows that pregnancy
with mosaic trisomy 2 in the fetus may manifest a low level of
MSPAPP-A in the first trimester.
The present case was associated with IUGR, severe oligo-
hydramnios, complete trisomy 2 in the placenta, and 50%
mosaicism for trisomy 2 in the amniotic membrane. Preg-
nancies with trisomy 2 cells in chorionic villi have been
known to be associated with IUGR, severe oligohydramnios
and adverse fetal outcome [1,7,15,17e22]. Pregnancies with
trisomy 2 cells in amniotic membrane have been found to have
poor pregnancy outcome even if the fetus has a normal kar-
yotype [28]. The present case was associated with congenital
heart defect, facial dysmorphism, preaxial polydactyly, and
mosaic trisomy 2 in the fetus. Mosaic trisomy 2 in live births
has been associated with phenotypic abnormalities such as
craniofacial dysmorphism of midface hypoplasia, micro/
anophthalmia, cleft lip and palate, hypertelorism and micro-
cephaly, growth and motor delay, congenital heart defects,
neural tube defects, diaphragmatic hernia, inguinal hernia,
radioulnar hypoplasia, rocker-bottom feet, caudal dysgenesis,
portal fibrosis, intestinal malrotation, Hirschsprung disease,
and hypomelanosis of Ito [8,11e13,15,23e27]. In addition,
the present case shows that preaxial polydactyly can be a
phenotypic feature of mosaic trisomy 2.
The present case provides evidence for cytogenetic
discrepancy between uncultured amniocytes and cultured
amniocytes in mosaic trisomy 2. In the repeated amniocentesis
in our case, mosaic trisomy 2 was evident in uncultured
amniocytes on interphase FISH and aCGH analyses, whereas
the conventional cytogenetic analysis of cultured amniocytes
revealed a normal karyotype. It is possible that the abnormal
cell line of trisomy 2 in amniotic fluid with mosaic trisomy 2
disappears after long-term culture. In the present case, the
placenta had trisomy 2, the amniotic membrane had 50%
mosaicism for trisomy 2, the fetal liver and umbilical cord had
10% mosaicism for trisomy 2, and the fetal lung, skin, and
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the hypothesis of origin of amnion in mosaicism, of which a
trisomic rescue occurs relatively late in the embryonic devel-
opment causing a few cells of the inner cell mass to be diploid
and resulting in cytogenetic discrepancies among placenta,
amniotic membrane, and fetal tissues, and a selection against
the trisomic cells. The discrepant mosaic trisomy 2 status in
our case can be explained by the hypothesis raised by Rob-
inson et al [28]. The present case also provides evidence that
cord blood sampling using cord blood and repeated amnio-
centesis using cultured amniocytes for confirmation of mosaic
trisomy 2 at amniocentesis are not practical.
In conclusion, we demonstrate the usefulness of application
of FISH and aCGH on uncultured amniocytes for rapid confir-
mation of low-level trisomy 2 mosaicism as well as differential
diagnosis of true mosaicism from pseudomosaicism at amnio-
centesis. The abnormal cell line of trisomy 2 in cases with
mosaic trisomy 2 may disappear after long-term cell culture,
therefore, we suggest the application of interphase FISH and
aCGH analyses to uncultured amniocytes for confirmation of
low-level mosaic trisomy 2 at repeated amniocentesis.Acknowledgments
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